Statement on Seasonal Influenza Vaccine for 2012-2013: Appendix I: New Evidence Review for Children 24 to 59 Months of Age: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).
出版信息
Can Commun Dis Rep. 2012 Aug 1;38(ACS-2):1-55. doi: 10.14745/ccdr.v38i00a02a.
Abstract
摘要
相似文献
1
Statement on Seasonal Influenza Vaccine for 2012-2013: Appendix I: New Evidence Review for Children 24 to 59 Months of Age: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).2012 - 2013年季节性流感疫苗声明：附录一：24至59月龄儿童的新证据审查：一份咨询委员会声明（ACS） 国家免疫咨询委员会（NACI）
Can Commun Dis Rep. 2012 Aug 1;38(ACS-2):1-55. doi: 10.14745/ccdr.v38i00a02a.
2
Summary of the National Advisory Committee on Immunization (NACI) Seasonal Influenza Vaccine Statement for 2023-2024.国家免疫咨询委员会（NACI）2023 - 2024年季节性流感疫苗声明摘要
Can Commun Dis Rep. 2023 Oct 1;49(10):406-412. doi: 10.14745/ccdr.v49i10a01.
3
Summary of the National Advisory Committee on Immunization (NACI) Statement on Seasonal Influenza Vaccine for 2016-2017.国家免疫咨询委员会（NACI）关于2016 - 2017年季节性流感疫苗声明摘要。
Can Commun Dis Rep. 2016 Sep 1;42(9):188-192. doi: 10.14745/ccdr.v42i09a06.
4
Summary of the National Advisory Committee on Immunization (NACI) Seasonal Influenza Vaccine Statement for 2022-2023.国家免疫咨询委员会（NACI）2022 - 2023年季节性流感疫苗声明摘要。
Can Commun Dis Rep. 2022 Sep 1;48(9):373-382.
5
Summary of the National Advisory Committee on Immunization (NACI) Seasonal Influenza Vaccine Statement for 2021-2022.国家免疫咨询委员会（NACI）2021 - 2022年季节性流感疫苗声明摘要。
Can Commun Dis Rep. 2021 Sep 10;47(9):372-380. doi: 10.14745/ccdr.v47i09a04.
6
Recommendations on the use of live, attenuated influenza vaccine (FluMist): Supplemental Statement on Seasonal Influenza Vaccine for 2011-2012 An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).关于使用减毒活流感疫苗（FluMist）的建议：2011 - 2012年季节性流感疫苗补充声明 免疫国家咨询委员会（NACI）咨询委员会声明（ACS）
Can Commun Dis Rep. 2011 Nov 30;37(ACS-7):1-77. doi: 10.14745/ccdr.v37i00a07.
7
Recommendations on the use of MF59-Adjuvanted Trivalent Influenza Vaccine (Fluad): Supplemental Statement of Seasonal Influenza Vaccine for 2011-2012 An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).关于使用MF59佐剂三价流感疫苗（Fluad）的建议：2011 - 2012年季节性流感疫苗补充声明 免疫咨询委员会声明（ACS） 国家免疫咨询委员会（NACI）
Can Commun Dis Rep. 2011 Oct 21;37(ACS-6):1-68. doi: 10.14745/ccdr.v37i00a06.
8
Summary of the National Advisory Committee on Immunization (NACI) Statement-Recommendation on Repeated Seasonal Influenza Vaccination.国家免疫咨询委员会（NACI）关于重复季节性流感疫苗接种声明-建议的总结。
Can Commun Dis Rep. 2023 Apr 1;49(4):99-102. doi: 10.14745/ccdr.v49i04a02.
9
Statement on Seasonal Influenza Vaccine for 2013-2014: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).2013 - 2014年季节性流感疫苗声明：免疫国家咨询委员会（NACI）的咨询委员会声明（ACS）
Can Commun Dis Rep. 2013 Oct 10;39(ACS-4):1-37. doi: 10.14745/ccdr.v39i00a04.
10
STATEMENT ON SEASONAL INFLUENZA VACCINE FOR 2012-2013: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).2012 - 2013年季节性流感疫苗声明：免疫国家咨询委员会（NACI）的咨询委员会声明（ACS）
Can Commun Dis Rep. 2012 Aug 1;38(ACS-2):1-36. doi: 10.14745/ccdr.v38i00a02.
本文引用的文献
1
Recommendations on the use of live, attenuated influenza vaccine (FluMist): Supplemental Statement on Seasonal Influenza Vaccine for 2011-2012 An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).关于使用减毒活流感疫苗（FluMist）的建议：2011 - 2012年季节性流感疫苗补充声明 免疫国家咨询委员会（NACI）咨询委员会声明（ACS）
Can Commun Dis Rep. 2011 Nov 30;37(ACS-7):1-77. doi: 10.14745/ccdr.v37i00a07.
2
Estimating the clinical impact of introducing paediatric influenza vaccination in England and Wales.评估在英格兰和威尔士引入儿童流感疫苗接种的临床影响。
Vaccine. 2012 Feb 1;30(6):1208-24. doi: 10.1016/j.vaccine.2011.11.106. Epub 2011 Dec 13.
3
Vaccine effectiveness for laboratory-confirmed influenza in children 6-59 months of age, 2005-2007.2005-2007 年期间，6-59 月龄儿童的实验室确诊流感疫苗效力。
Vaccine. 2011 Nov 8;29(48):9005-11. doi: 10.1016/j.vaccine.2011.09.037. Epub 2011 Sep 21.
4
Effect of expanded US recommendations for seasonal influenza vaccination: comparison of two pediatric emergency departments in the United States and Canada.美国扩大季节性流感疫苗接种建议的效果：美国和加拿大两家儿科急诊部门的比较。
CMAJ. 2011 Sep 20;183(13):E1025-32. doi: 10.1503/cmaj.110241.
5
Influenza Β/Victoria antigen induces strong recall of Β/Yamagata but lower Β/Victoria response in children primed with two doses of Β/Yamagata.乙型/Victoria 抗原在两剂乙型/Yamagata 疫苗接种的儿童中诱导强烈的 Β/Yamagata 回忆反应，但乙型/Victoria 反应较低。
Pediatr Infect Dis J. 2011 Oct;30(10):833-9. doi: 10.1097/INF.0b013e31822db4dc.
6
Safety of trivalent inactivated influenza vaccine in children aged 24 to 59 months in the vaccine safety datalink.疫苗安全数据链中24至59个月大儿童使用三价灭活流感疫苗的安全性
Arch Pediatr Adolesc Med. 2011 Aug;165(8):749-55. doi: 10.1001/archpediatrics.2011.112.
7
Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6-59 months of age.6-59 月龄儿童中安阿伯株活减毒流感疫苗病毒的脱落。
Vaccine. 2011 Jun 10;29(26):4322-7. doi: 10.1016/j.vaccine.2011.04.022. Epub 2011 Apr 20.
8
The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults.三价活减毒流感疫苗和灭活流感疫苗在儿童和成人中的相对疗效。
Influenza Other Respir Viruses. 2011 Mar;5(2):67-75. doi: 10.1111/j.1750-2659.2010.00183.x. Epub 2010 Nov 19.
9
The effectiveness of trivalent inactivated influenza vaccine in children over six consecutive influenza seasons.六连个流感季中三价灭活流感疫苗在儿童中的效果。
Vaccine. 2011 Feb 17;29(9):1844-9. doi: 10.1016/j.vaccine.2010.12.049. Epub 2010 Dec 31.
10
Effectiveness of inactivated influenza vaccine in children aged 9 months to 3 years: an observational cohort study.9 月龄至 3 岁儿童接种流感灭活疫苗的有效性：一项观察性队列研究。
Lancet Infect Dis. 2011 Jan;11(1):23-9. doi: 10.1016/S1473-3099(10)70255-3. Epub 2010 Nov 22.
Zotero 插件